Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Parenteral Drugs (India): Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal
News Announcement

Parenteral Drugs (India): Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal

22-Jan-2025 Follow Value Research Online on Google download pdfDownload PDF Parenteral Drugs

According to Regulation 30 of SEBI(Listing Obligation and Disclosure Requirements) Requirements 2015 (Listing Regulations) and in accordance with the requirements of Sub- clause 16(k) of Para A of part A of Schedule III of Listing Regulations we wish to inform you that the Honble NCLT Mumbai has approved the resolution plan in the matter of the Corporate Debtor namely parenteral Drugs (india) Ltd. vide their order dated 16.01.2025.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan